Characterization of antimicrobial resistance mechanisms in carbapenem-resistant Pseudomonas aeruginosa carrying IMP variants recovered from a Mexican Hospital

References

• Meletis G, Exindari M, Vavatsi N, Sofianou D, Diza E. Mechanisms responsible for the emergence of carbapenem resistance in Pseudomonas aeruginosa. Hippokratia. 2012;16(4):303–307.
   PubMed Web of Science ®Google Scholar
• Ruppé É, Woerther PL, Barbier F. Mechanisms of antimicrobial resistance in Gram-negative bacilli. Ann Intensive Care. 2015;5(1):61.
   PubMed Web of Science ®Google Scholar
• Hong DJ, Bae IK, Jang IH, et al. Epidemiology and characteristics of metallo-β-lactamase-producing Pseudomonas aeruginosa. Infect Chemother. 2015;47(2):81–97.
   PubMed Web of Science ®Google Scholar
• Watanabe M, Iyobe S, Inoue M, Mitsuhashi S. Transferable imipenem resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother. 1991;35(1):147–151.
   PubMed Web of Science ®Google Scholar
• Zhao WH, Hu ZQ, Zq H. IMP-type metallo-β-lactamases in Gram-negative bacilli: distribution, phylogeny, and association with integrons. Crit Rev Microbiol. 2011;37(3):214–226.
   PubMed Web of Science ®Google Scholar
• Pournaras S, Köck R, Mossialos D, et al. Detection of a phylogenetically distinct IMP-type metallo-β-lactamase, IMP-35, in a CC235 Pseudomonas aeruginosa from the Dutch-German border region (Euregio). J Antimicrob Chemother. 2013;68(6):1271–1276.
   PubMed Web of Science ®Google Scholar
• Mano Y, Saga T, Ishii Y, et al. Molecular analysis of the integrons of metallo-β-lactamase-producing Pseudomonas aeruginosa isolates collected by nationwide surveillance programs across Japan. BMC Microbiol. 2015;15:41.
   PubMed Web of Science ®Google Scholar
• Martínez T, Vázquez GJ, Aquino EE, Goering RV, Robledo IE. Two novel class I integron arrays containing IMP-18 metallo-β-lactamase gene in Pseudomonas aeruginosa clinical isolates from Puerto Rico. Antimicrob Agents Chemother. 2012;56(4):2119–2121.
   PubMed Web of Science ®Google Scholar
• Sánchez-Martinez G, Garza-Ramos UJ, Reyna-Flores FL, et al. In169, a new class 1 integron that encoded bla(IMP-18) in a multidrug-resistant Pseudomonas aeruginosa isolate from Mexico. Arch Med Res. 2010;41(4):235–239.
   PubMed Web of Science ®Google Scholar
• Garza-Ramos U, Morfin-Otero R, Sader HS, et al. Metallo-beta-lactamase gene bla(IMP-15) in a class 1 integron, In95, from Pseudomonas aeruginosa clinical isolates from a hospital in Mexico. Antimicrob Agents Chemother. 2008;52(8):2943–2946.
   PubMed Web of Science ®Google Scholar
• Garza-Ramos U, Tinoco P, Silva-Sanchez J, et al. Metallo-beta-lactamase IMP-18 is located in a class 1 integron (In96) in a clinical isolate of Pseudomonas aeruginosa from Mexico. Int J Antimicrob Agents. 2008;31(1):78–80.
   PubMed Web of Science ®Google Scholar
• Quinones-Falconi F, Galicia-Velasco M, Marchiaro P, et al. Emergence of Pseudomonas aeruginosa strains producing metallo-beta-lactamases of the IMP-15 and VIM-2 types in Mexico. Clin Microbiol Infect. 2010;16(2):126–131.
   PubMed Web of Science ®Google Scholar
• Xiong J, Hynes MF, Ye H, et al. bla(IMP-9) and its association with large plasmids carried by Pseudomonas aeruginosa isolates from the People’s Republic of China. Antimicrob Agents Chemother. 2006;50(1):355–358.
   PubMed Web of Science ®Google Scholar
• Liu J, Yang L, Chen D, et al. Complete sequence of pBM413, a novel multidrug resistance megaplasmid carrying qnrVC6 and blaIMP-45 from Pseudomonas aeruginosa. Int J Antimicrob Agents. 2018;51(1):145–150.
   PubMed Web of Science ®Google Scholar
• Sagai H, Hasuda K, Iyobe S, et al. Classification of R plasmids by incompatibility in Pseudomonas aeruginosa. Antimicrob Agents Chemother. 1976;10(4):573–578.
   PubMed Web of Science ®Google Scholar
• Boronin AM. Diversity of Pseudomonas plasmids: to what extent? FEMS Microbiol Lett. 1992;100(1-3):461–467.
   PubMed Web of Science ®Google Scholar
• Alvarado A, Garcillán-Barcia MP, de La Cruz F. A degenerate primer MOB typing (DPMT) method to classify gamma-proteobacterial plasmids in clinical and environmental settings. PLoS One. 2012;7(7):e40438–15.
   PubMed Web of Science ®Google Scholar
• Wolter DJ, Hanson ND, Lister PD. Insertional inactivation of oprD in clinical isolates of Pseudomonas aeruginosa leading to carbapenem resistance. FEMS Microbiol Lett. 2004;236(1):137–143.
   PubMed Web of Science ®Google Scholar
• Rojo-Bezares B, Estepa V, Cebollada R, et al. Carbapenem-resistant Pseudomonas aeruginosa strains from a Spanish hospital: characterization of metallo-beta-lactamases, porin OprD and integrons. Int J Med Microbiol. 2014;304(3-4):405–414.
   PubMed Web of Science ®Google Scholar
• Ruiz-Martínez L, López-Jiménez L, D’Ostuni V, et al. A mechanism of carbapenem resistance due to a new insertion element (ISPa133) in Pseudomonas aeruginosa. Int Microbiol. 2011;14(1):51–58.
   PubMed Web of Science ®Google Scholar
• Poole K, Krebes K, Mcnally C, Neshat S. Multiple antibiotic resistance in Pseudomonas aeruginosa: evidence for involvement of an efflux operon. J Bacteriol. 1993;175(22):7363–7372.
   PubMed Web of Science ®Google Scholar
• Poole K, Gotoh N, Tsujimoto H, et al. Overexpression of the mexC-mexD-oprJ efflux operon in nfxB-type multidrug-resistant strains of Pseudomonas aeruginosa. Mol Microbiol. 1996;21(4):713–725.
   PubMed Web of Science ®Google Scholar
• Köhler T, Michéa-Hamzehpour M, Henze U, et al. Characterization of MexE-MexF-OprN, a positively regulated multidrug efflux system of Pseudomonas aeruginosa. Mol Microbiol. 1997;23(2):345–354.
   PubMed Web of Science ®Google Scholar
• Aires JR, Köhler T, Nikaido H, Plésiat P. Involvement of an active efflux system in the natural resistance of Pseudomonas aeruginosa to aminoglycosides. Antimicrob Agents Chemother. 1999;43(11):2624–2628.
   PubMed Web of Science ®Google Scholar
• Chalhoub H, Sáenz Y, Rodríguez-Villalobos H, et al. High-level resistance to meropenem in clinical isolates of Pseudomonas aeruginosa in the absence of carbapenemases: role of active efflux and porin alterations. Int J Antimicrob Agents. 2016;48(6):740–743.
   PubMed Web of Science ®Google Scholar
• Eshra KA, Shalaby MM. Efflux pump inhibition effect of curcumin and phenylalanine arginyl β- naphthylamide (PAβN) against multidrug resistant Pseudomonas aeruginosa isolated from burn infections in Tanta University Hospitals. Egypt J Med Microbiol. 2017;26(1):113–119.
   Google Scholar
• Clinical and Laboratory Standards Institute (CLSI) M100. Performance Standards for Antimicrobial Susceptibility Testing. 28th ed. USA: Clinical and Laboratory Standards Institute; 2018.
   Google Scholar
• Magiorakos AP, Srinivasan A, Carey RB, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268–281.
   PubMed Web of Science ®Google Scholar
• Rojo-Bezares B, Estepa V, de Toro M, et al. A novel class 1 integron array carrying blaVIM-2 genes and a new insertion sequence in a Pseudomonas aeruginosa strain isolated from a Spanish hospital. J Med Microbiol. 2011;60(Pt 7):1053–1054.
   PubMed Web of Science ®Google Scholar
• Tenover FC, Arbeit RD, Goering RV, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol. 1995;33(9):2233–2239.
   PubMed Web of Science ®Google Scholar
• Curran B, Jonas D, Grundmann H, Pitt T, Dowson CG. Development of a multilocus sequence typing scheme for the opportunistic pathogen Pseudomonas aeruginosa. J Clin Microbiol. 2004;42(12):5644–5649.
   PubMed Web of Science ®Google Scholar
• Jolley KM. Pseudomonas aeruginosa MLST Database, University of Oxford. BMC Bioinformatics. [updated. 2018 June 4; cited 2010 December 10]. Available from: https://pubmlst.org/paeruginosa/. Accessed June 10, 2018.
   Google Scholar
• Lévesque C, Piché L, Larose C, Roy PH, Ch L. PCR mapping of integrons reveals several novel combinations of resistance genes. Antimicrob Agents Chemother. 1995;39(1):185–191.
   PubMed Web of Science ®Google Scholar
• Gorgani N, Ahlbrand S, Patterson A, Pourmand N. Detection of point mutations associated with antibiotic resistance in Pseudomonas aeruginosa. Int J Antimicrob Agents. 2009;34(5):414–418.
   PubMed Web of Science ®Google Scholar
• Gutiérrez O, Juan C, Cercenado E, et al. Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa isolates from Spanish hospitals. Antimicrob Agents Chemother. 2007;51(12):4329–4335.
   PubMed Web of Science ®Google Scholar
• Wolter DJ, Hanson ND, Lister PD. Insertional inactivation of oprD in clinical isolates of Pseudomonas aeruginosa leading to carbapenem resistance. FEMS Microbiol Lett. 2004;236(1):137–143.
   PubMed Web of Science ®Google Scholar
• Kumita W, Saito R, Sato K, et al. Molecular characterizations of carbapenem and ciprofloxacin resistance in clinical isolates of Pseudomonas putida. J Infect Chemother. 2009;15(1):6–12.
   PubMed Web of Science ®Google Scholar
• Green MR, Sambrook J. Molecular Cloning: A Laboratory Manual. 4th ed. New York: Cold Spring Harbor Laboratory Press; 2012.
   Google Scholar
• Kaufmann ME. Pulsed-field gel electrophoresis. Methods Mol Med. 1998;15:33–50.
   PubMedGoogle Scholar
• Carattoli A, Bertini A, Villa L, et al. Identification of plasmids by PCR-based replicon typing. J Microbiol Methods. 2005;63(3):219–228.
   PubMed Web of Science ®Google Scholar
• Oliver A. Epidemiology and carbapenem resistance mechanisms in Pseudomonas aeruginosa: role of high-risk clones in multidrug resistance. Enferm Infecc Microbiol Clin. 2017;35(3):137–138.
   PubMed Web of Science ®Google Scholar
• Hanson ND, Hossain A, Buck L, Moland ES, Thomson KS. First occurrence of a Pseudomonas aeruginosa isolate in the United States producing an IMP metallo-beta-lactamase, IMP-18. Antimicrob Agents Chemother. 2006;50(6):2272–2273.
   PubMed Web of Science ®Google Scholar
• Castillo-Vera J, Ribas-Aparicio RM, Nicolau CJ, et al. Unusual diversity of acquired β-lactamases in multidrug-resistant Pseudomonas aeruginosa isolates in a Mexican hospital. Microb Drug Resist. 2012;18(5):471–478.
   PubMed Web of Science ®Google Scholar
• Partridge SR, Tsafnat G, Coiera E, Iredell JR. Gene cassettes and cassette arrays in mobile resistance integrons. FEMS Microbiol Rev. 2009;33(4):757–784.
   PubMed Web of Science ®Google Scholar
• Oliver A, Mulet X, López-Causapé C, Juan C. The increasing threat of Pseudomonas aeruginosa high-risk clones. Drug Resist Updat. 2015;21-22(22):41–59.
   PubMed Web of Science ®Google Scholar
• Espinosa-Camacho LF, Delgado G, Soberón-Chávez G, et al. Complete genome sequences of four extensively drug-resistant Pseudomonas aeruginosa strains, isolated from adults with ventilator-associated pneumonia at a tertiary referral hospital in Mexico City. Genome Announc. 2017;5(36):e00925-17–3.
   Google Scholar
• Ocampo-Sosa AA, Cabot G, Rodríguez C, et al. Alterations of OprD in carbapenem-intermediate and -susceptible strains of Pseudomonas aeruginosa isolated from patients with bacteremia in a Spanish multicenter study. Antimicrob Agents Chemother. 2012;56(4):1703–1713.
   PubMed Web of Science ®Google Scholar
• Sun Q, Ba Z, Wu G, et al. Insertion sequence ISRP10 inactivation of the oprD gene in imipenem-resistant Pseudomonas aeruginosa clinical isolates. Int J Antimicrob Agents. 2016;47(5):375–379.
   PubMed Web of Science ®Google Scholar
• Wolter DJ, Khalaf N, Robledo IE, et al. Surveillance of carbapenem-resistant Pseudomonas aeruginosa isolates from Puerto Rico Medical Center Hospitals: dissemination of KPC and IMP-18 beta-lactamases. Antimicrob Agents Chemother. 2009;53(4):1660–1664.
   PubMed Web of Science ®Google Scholar
• Rodríguez-Martínez JM, Poirel L, Nordmann P. Extended-spectrum cephalosporinases in Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2009;53(5):1766–1771.
   PubMed Web of Science ®Google Scholar
• Epp SF, Köhler T, Plésiat P, et al. C-terminal region of Pseudomonas aeruginosa outer membrane porin OprD modulates susceptibility to meropenem. Antimicrob Agents Chemother. 2001;45(6):1780–1787.
   PubMed Web of Science ®Google Scholar
• El’garch F, Jeannot K, Hocquet D, Llanes-Barakat C, Plésiat P. Cumulative effects of several nonenzymatic mechanisms on the resistance of Pseudomonas aeruginosa to aminoglycosides. Antimicrob Agents Chemother. 2007;51(3):1016–1021.
   PubMed Web of Science ®Google Scholar
• Lamers RP, Cavallari JF, Burrows LL. The efflux inhibitor phenylalanine-arginine beta-naphthylamide (PAβN) permeabilizes the outer membrane of gram-negative bacteria. PLoS One. 2013;8(3):e60666.
   PubMed Web of Science ®Google Scholar
• Dai X, Zhou D, Xiong W, et al. The IncP-6 plasmid p10265-KPC from Pseudomonas aeruginosa carries a novel ΔISEc33-associated bla KPC-2 gene cluster. Front Microbiol. 2016;7:310.
   PubMed Web of Science ®Google Scholar
• Popowska M, Krawczyk-Balska A. Broad-host-range IncP-1 plasmids and their resistance potential. Front Microbiol. 2013;4:44.
   PubMed Web of Science ®Google Scholar
• Bahl MI, Burmølle M, Meisner A, Hansen LH, Sørensen SJ. All IncP-1 plasmid subgroups, including the novel epsilon subgroup, are prevalent in the influent of a Danish wastewater treatment plant. Plasmid. 2009;62(2):134–139.
   PubMed Web of Science ®Google Scholar